• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL TRIFECTA¿; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL TRIFECTA¿; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-23A
Medical Device Problem Code Degraded (1153)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 02/25/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
It is unknown if the device is returning for analysis.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported that in 2014, a 23mm trifecta valve was implanted.On (b)(6) 2025, a 23mm navitor valve was selected for implant in an off-label use.The navitor was going to be implanted within the 23mm trifecta valve.A pre-dilation was performed with a 22mm balloon.The navitor was able to be successfully implanted and the same balloon used for the pre-dilation was used to post-dilate the valve.The result was excellent.There was no gradient and no pvl.The healthcare professional doesn't believe the patient or user experienced adverse health consequences due to the performance of the product.
 
Additional Manufacturer Narrative
An event of shortness of breath, difficulty urinating, extreme fatigue, and defective device was reported.A more comprehensive assessment, including histopathological examination of the valve tissue could not be performed as the device was not returned for analysis.The device history record was also reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.Based on the available information, the cause of the reported general structural valve deterioration could not be conclusively determined.The reported surgery was the result of case-specific circumstances.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
 
Event or Problem Description
It was reported that in 2014, a 23mm trifecta valve was implanted.On (b)(6) 2025, a 23mm navitor valve was selected for implant in an off-label use.The navitor was going to be implanted within the 23mm trifecta valve.A pre-dilation was performed with a 22mm balloon.The navitor was able to be successfully implanted and the same balloon used for the pre-dilation was used to post-dilate the valve.The result was excellent.There was no gradient and no pvl.The healthcare professional doesn't believe the patient or user experienced adverse health consequences due to the performance of the product.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIFECTA¿
Common Device Name
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key21652683
Report Number2135147-2025-01428
Device Sequence Number18012419
Product Code LWR
UDI-Device Identifier05414734052030
UDI-Public(01)05414734052030(17)160325
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
P100029
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2014
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/05/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/25/2016
Device Model NumberTF-23A
Device Catalogue NumberTF-23A
Device Lot Number4574784
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 02/25/2025
Supplement Date Received by Manufacturer04/11/2025
Initial Report FDA Received Date03/20/2025
Supplement Report FDA Received Date05/05/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/27/2014
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age81 YR
Patient SexFemale
-
-